Citation Impact
Citing Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Breast cancer
2019 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging
2005 StandoutNobel
Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases
2010 Standout
Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma
2005
Tumor acidity, ion trapping and chemotherapeutics
2003
Hyperthermia in combined treatment of cancer
2002 Standout
Hyperthermic Isolation Limb Perfusion for Malignant Melanoma: A Review
1992
Sturge–Weber Syndrome and Port-Wine Stains Caused by Somatic Mutation in GNAQ
2013 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Heating the patient: a promising approach?
2002 Standout
Radical lymph node dissection for melanoma
2003
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Melanoma Recurrence Patterns After Negative Sentinel Lymphadenectomy
2005
The hidden sentinel node in breast cancer
2002
The cellular and molecular basis of hyperthermia
2002 Standout
Esophageal Cancer
2003 Standout
The use of dendritic cells in cancer immunotherapy
2003 StandoutNobel
Sentinel-Node Biopsy or Nodal Observation in Melanoma
2006 Standout
Soft-Tissue Sarcomas in Adults
2005 Standout
Sentinel Node Skills Verification and Surgeon Performance
2005
Intraperitoneal Cisplatin plus Intravenous Cyclophosphamide versus Intravenous Cisplatin plus Intravenous Cyclophosphamide for Stage III Ovarian Cancer
1996 Standout
Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma
2005
SENTINEL NODE STAGING OF EARLY BREAST CANCER USING LYMPHOSCINTIGRAPHY AND THE INTRAOPERATIVE GAMMA DETECTING PROBE
2001
Tumor acidity, ion trapping and chemotherapeutics
2003
Lymphatic mapping and sentinel node biopsy for melanoma
2001
Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping
2003 StandoutNobel
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Patterns of early recurrence after sentinel lymph node biopsy for melanoma
2002
Isolated limb perfusion in locally advanced cutaneous melanoma
2002
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas
2005
Management of Cutaneous Melanoma
2004
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible Light
2006 StandoutNobel
Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: A systematic review
2009
Targeting apoptosis in cancer therapy
2020 Standout
Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases
2010
Facial port-wine stains – clinical stratification and risks of neuro-ocular involvement
2007
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
2013 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline – Update 2016
2016
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
2003
Melanoma–stroma interactions: structural and functional aspects
2002
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Prognostic Factors in Patients With Melanoma Metastatic to Axillary or Inguinal Lymph Nodes
1991
Hyperthermia adds to chemotherapy
2008
Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis
2011 Standout
Tumor necrosis factor signaling
2003 Standout
Complications Associated With Sentinel Lymph Node Biopsy for Melanoma
2003
Detection of micrometastatic breast cancer by means of real time quantitative RT‐PCR and immunostaining in perioperative blood samples and sentinel nodes
2003
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer
2013 Standout
Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: Credits, debits, and future perspectives
2001
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2019 Standout
Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy is Accurate and Reduces the Need for Axillary Dissection in Breast Cancer Patients
2009
Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma
2015
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
2010 Standout
Lymphedema beyond breast cancer
2010 Standout
Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: Cessation of CTL responses is associated with disease progression
2001
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature
2010
Radiation safety of the sentinel lymph node technique in breast cancer
2000
How many cases are enough for accreditation in sentinel lymph node biopsy in breast cancer?
2003
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Nuclear medicine aspects of melanoma and breast lymphatic mapping
2004
Imaging and cancer: A review
2008
Drug Resistance and the Solid Tumor Microenvironment
2007 Standout
Revisiting the biological roles of PAI2 (SERPINB2) in cancer
2008
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
2012 Standout
Electrochemotherapy – An easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study
2006
Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer
2000
Nanoparticles for photothermal therapies
2014 Standout
Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavity
1986
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System
2001 Standout
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Breast Cancer Survivorship: A Comprehensive Review of Long-Term Medical Issues and Lifestyle Recommendations
2015
The preparation of magnetic nanoparticles for applications in biomedicine
2003 Standout
Breast Cancer Treatment
2019 Standout
The Risk of In-Transit Melanoma Metastasis Depends on Tumor Biology and Not the Surgical Approach to Regional Lymph Nodes
2005
Applications of magnetic nanoparticles in biomedicine
2003 Standout
Engineered PLGA microparticles for long-term, pulsatile release of STING agonist for cancer immunotherapy
2020
Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
2001 Standout
Long-Term Results of Tumor Necrosis Factor α– and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
2011
Prognostic Factors in Patients with Melanoma Metastatic to Regional Nodes
1992
Esophageal Cancer: The Mode of Lymphatic Tumor Cell Spread and Its Prognostic Significance
2001
TNF-α in Cancer Treatment: Molecular Insights, Antitumor Effects, and Clinical Utility
2006
Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study
2004 Standout
Sentinel Lymphadenectomy Does Not Increase the Incidence of In-Transit Metastases in Primary Melanoma
2005
Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy
2007
Works of B.B.R. Kroon being referenced
Lymph node metastases in the neck and parotid gland from an unknown primary melanoma
1994
Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer
1996
The illusion of the learning phase for lymphatic mapping
2002
Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: results of a multicenter randomized phase III trial. European Organization for Research and Treatment of Cancer Malignant Melanoma Cooperative Group Protocol 18832, the World Health Organization Melanoma Program Trial 15, and the North American Perfusion Group Southwest Oncology Group-8593.
1998
The Additional Value of SPECT/CT in Lymphatic Mapping in Breast Cancer and Melanoma
2007
Vascular complications of isolated limb perfusion
1998
Palliative isolated limb perfusion for advanced limb disease in stage IV melanoma patients
2005
High tPA-expression in primary melanoma of the limb correlates with good prognosis
2000
A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities
1995
Safety and efficacy of isolated limb perfusion in elderly melanoma patients
2002
Modification of human tumour and normal tissue pH during hyperthermic and normothermic antiblastic regional isolation perfusion for malignant melanoma: a pilot study
1993
Repeat isolated limb perfusion with TNFα and melphalan for recurrent limb melanoma after failure of previous perfusion
2006
To perfuse or not to perfuse? A retrospective comparative study to evaluate the effect of adjuvant isolated regional perfusion in patients with stage I extremity melanoma with a thickness of 1.5 mm or greater.
1988
Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients
2002
Identification and biopsy of the sentinel lymph node in breast cancer
1998
Technique of sentinel node biopsy in breast cancer
1998
The health-related quality of life of long-term survivors of melanoma treated with isolated limb perfusion
2007
Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities
1989
Topical dinitrochlorobenzene combined with systemic dacarbazine in the treatment of recurrent melanoma
1997
Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- α versus toxicity after melphalan alone
2001
Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: A systematic review and meta-analysis of the literature
2008
Lymph node metastasis from melanoma with an unknown primary site
1990
Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.
1988
Results of radical dissection of the groin in patients with stage II melanoma and histologically proved metastases of the iliac or obturator lymph nodes, or both.
1988
Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs.
1987
Lymphatic mapping and selective lymphadenectomy for melanoma: not yet standard therapy
1997
Systemic leakage during isolated limb perfusion for melanoma
1993
Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan
1999
Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics.
1988
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.
1994
High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma
2004
The Denver type for peritoneovenous shunting of malignant ascites.
1986
Reliability of sentinel lymph node biopsy for staging melanoma
2000